Recombinant gp350 vaccine for infectious mononucleosis : a phase 2, randomized, double-blind, placebo-controlled a. trial to evaluate the safety, immunogenicity, and efficacy of an Epstein-Barr virus vaccine in healthy young adults

• SOKAL E. M.

収録刊行物

• J Infect Dis.

  J Infect Dis. 196 1749-1753, 2007

詳細情報

• CRID: 1571698600524960896
• NII論文ID: 10021242644
• データソース種別:
  • CiNii Articles